RHINO-LARYNGOFIBERSCOPE ENF-T3

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a user facility report with the FDA on 2019-04-25 for RHINO-LARYNGOFIBERSCOPE ENF-T3 manufactured by Olympus Medical Systems Corp..

Event Text Entries

[143032238] The device was returned to omsc for evaluation but the evaluation is still in progress. The exact cause of the reported event could not be conclusively determined at this time. If additional information is provided, this report will be supplemented.
Patient Sequence No: 1, Text Type: N, H10


[143032239] Olympus medical systems corp. (omsc) was informed that the user facility aborted a diagnostic procedure since the insertion tube of the subject device broke. The patient had a slight bleeding. According to a picture provided by the reporting person, the coating of the insertion tube partially peeled off.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010047-2019-01841
MDR Report Key8548002
Report SourceUSER FACILITY
Date Received2019-04-25
Date of Report2019-06-25
Date Mfgr Received2019-05-30
Device Manufacturer Date2002-09-09
Date Added to Maude2019-04-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR KAZUTAKA MATSUMOTO
Manufacturer Street2951 ISHIKAWA-CHO
Manufacturer CityHACHIOJI-SHI, TOKYO-TO 192-8507
Manufacturer CountryJA
Manufacturer Postal192-8507
Manufacturer Phone426425177
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameRHINO-LARYNGOFIBERSCOPE
Generic NameRHINO-LARYNGOFIBERSCOPE
Product CodeEOB
Date Received2019-04-25
Model NumberENF-T3
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerOLYMPUS MEDICAL SYSTEMS CORP.
Manufacturer Address2951 ISHIKAWA-CHO HACHIOJI-SHI, TOKYO-TO US


Patients

Patient NumberTreatmentOutcomeDate
10 2019-04-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.